THIS SOUNDS FIXABLE!
Mon, December 18, 2023, 7:31 AM EST
In this article:
CKPT
+2.86%
Dec 18 (Reuters) - Checkpoint Therapeutics said on Monday the U.S. Food and Drug Administration declined to approve its experimental therapy to treat a type of advanced skin cancer, citing issues related to a third-party contract manufacturer.
THE FACT THAT IT IS UP TODAY SAYS SOMETHING....
Mon, December 18, 2023, 7:31 AM EST
In this article:
CKPT
+2.86%
Dec 18 (Reuters) - Checkpoint Therapeutics said on Monday the U.S. Food and Drug Administration declined to approve its experimental therapy to treat a type of advanced skin cancer, citing issues related to a third-party contract manufacturer.
THE FACT THAT IT IS UP TODAY SAYS SOMETHING....
